SEC Comment Letter for REPLIGEN CORP (RGEN) (CIK 0000730272) (RGEN) — Feb 25, 2015
REPLIGEN CORP (RGEN) (CIK 0000730272)
Date: Feb. 25, 2015 · CIK: 0000730272 · Accession: 0000000000-15-011952
AI Filing Summary & Sentiment
Show Raw Text
February 25, 2015 Via E -mail Mr. Jon Snodgres Chief Financial Officer Repligen Corporation 41 Seyon Street, Building 1, Suite 100 Waltham, MA 82453 Re: Repligen Corporation Form 10-K for Fiscal Year Ended December 31, 2013 Filed March 14, 2014 File No. 000 -14656 Dear Mr. Snodgres : We have completed our review of your filing . We remind you that our comments or changes to disclosure in response to our comments do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We u rge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing include s the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Jeffrey P. Riedler Jeffrey P. Ried ler Assistant Director